MARKET DEFINITION

Utilizing genomic information, the scientific field of genomic medicine investigates how DNA interacts with health. They can collect data about a person's typical biological traits and use it for successful treatment. A growing field of medicine called genomic medicine examines the effects of clinical usage of genetic information on patient outcomes and policy implications (e.g., for diagnostic or therapeutic decision-making). In the areas of oncology, pharmacology, rare and unidentified disorders, and infectious diseases, genomic medicine is already having an impact.

MARKET DYNAMICS

Over the forecast period, the global market for genomic therapeutics will grow as a result of expanding research and developments in the pharmaceutical industry. The growth of government efforts, individual investments, and an increase in the applications of genetic studies in the healthcare sector will all contribute to the expansion of the global market for genomic medicine. It is projected that expanding government funding for precision medicine would drive industrial growth. Other factors including expanding genomic application areas, an increase in genomics initiatives, and rising demand for better sequencing in cancer, pharmacogenomics, and uncommon condition identification will cause the market to rise at a quicker rate.

REPORT SCOPE

The report titled “Global Genomic Medicine Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the Global Genomic Medicine market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Genomic Medicine market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Genomic Medicine Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Genomic Medicine Market is segmented based on application, end-user and region. Based on the application, the market is segmented into oncology, cardiology, paediatrics, endocrinology, respiratory medicine, rare genetic disorders, infectious diseases and others. End-users are further segmented into hospitals, clinics, academic institutions and research institutions.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Genomic Medicine market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Genomic Medicine market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Genomic Medicine market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Genomic Medicine Market industry in the past three years.

Key players in the Global Genomic Medicine Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• Genome Medical, Inc.
• BioMed Central Ltd
• Aevi Genomic Medicine, Inc.
• Congenica Ltd.
• Deep Genomics
• Editas Medicine
• Illumina, Inc.
• QIAGEN N.V. (Thermo Fisher Scientific)
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche Ltd.
• BGI

COVID-19 IMPACT ANALYSIS ON THE GLOBAL GENOMIC MEDICINE MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global Genomic Medicine market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Genomic Medicine market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What is the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the Genomic Medicine market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Placement
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Application Trends
3.2.2. End-User Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Genomic Medicine Market
3.6. COVID-19 Impact Assessment in Genomic Medicine Market
3.6.1. Impact Assessment on Global Genomic Medicine Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4. Global Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
4.1. Global Genomic Medicine Market Share, By Application, 2017 - 2028 (USD Million)
4.1.1. Oncology
4.1.2. Cardiology
4.1.3. Paediatrics
4.1.4. Endocrinology
4.1.5. Respiratory Medicine
4.1.6. Rare Genetic Disorders
4.1.7. Infectious Diseases
4.1.8. Others

Chapter 5. Global Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
5.1. Global Genomic Medicine Market Share, By End-User, 2017 - 2028 (USD Million)
5.1.1. Hospitals
5.1.2. Clinics
5.1.3. Academic Institutions
5.1.4. Research Institutions

Chapter 6. Global Genomic Medicine Market Overview, By Geography, 2017 - 2028 (USD Million)
6.1. Global Genomic Medicine Market Share, By Geography, 2017 - 2028 (USD Million)
6.1.1. Market End-User and Projections, by Countries, 2017 - 2028 (USD Million)
6.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 7. North America Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
7.1. North America Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
7.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
7.1.2. North America Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
7.1.3. North America Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
7.2. North America Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
7.2.1. U.S. Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
7.2.1.1. U.S. Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
7.2.1.2. U.S. Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
7.2.2. Canada Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
7.2.2.1. Canada Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
7.2.2.2. Canada Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
7.2.3. Mexico Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
7.2.3.1. Mexico Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
7.2.3.2. Mexico Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 8. Europe Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. Europe Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
8.1.2. Europe Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.1.3. Europe Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2. Europe Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. Germany Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. Germany Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.1.2. Germany Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.2. France Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. France Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.2.2. France Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.3. UK Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. UK Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.3.2. UK Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.4. Italy Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.2.4.1. Italy Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.4.2. Italy Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.5. Spain Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.2.5.1. Spain Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.5.2. Spain Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.6. NORDIC Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.2.6.1. NORDIC Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.6.2. NORDIC Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.7. Russia and CIS Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.2.7.1. Russia and CIS Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.7.2. Russia and CIS Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
8.2.8. Rest of Europe Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
8.2.8.1. Rest of Europe Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.8.2. Rest of Europe Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 9. Asia Pacific Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Asia Pacific Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
9.1.2. Asia Pacific Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
9.1.3. Asia Pacific Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2. Asia Pacific Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. India Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. India Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.1.2. India Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.2. China Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. China Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.2.2. China Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.3. Japan Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Japan Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.3.2. Japan Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.4. ASEAN Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. ASEAN Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.4.2. ASEAN Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.5. South Korea Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. South Korea Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.5.2. South Korea Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.6. Australia Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. Australia Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.6.2. Australia Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
9.2.7. Rest of Asia Pacific Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Rest of Asia Pacific Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.7.2. Rest of Asia Pacific Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 10. South America Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. South America Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
10.1.2. South America Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
10.1.3. South America Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2. South America Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Brazil Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Brazil Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.1.2. Brazil Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.2. Argentina Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. Argentina Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.2.2. Argentina Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
10.2.3. Rest of South America Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Rest of South America Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.3.2. Rest of South America Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 11. Middle East & Africa Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Middle East & Africa Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market End-User and projections, 2017 - 2028 (USD Million)
11.1.2. Middle East & Africa Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
11.1.3. Middle East & Africa Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2. Middle East & Africa Genomic Medicine Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. GCC Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. GCC Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.1.2. GCC Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.2. South Africa Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. South Africa Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.2.2. South Africa Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)
11.2.3. Rest of Middle East & Africa Genomic Medicine Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of Middle East & Africa Genomic Medicine Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.3.2. Rest of Middle East & Africa Genomic Medicine Market Overview, By End-User, 2017 - 2028 (USD Million)

Chapter 12. Competitive Landscape
12.1. Competitive Environment, 2021
12.2. Strategic Framework
12.2.1. Partnership/Collaborations/Agreement
12.2.2. Expansion
12.2.3. Mergers & Acquisitions
12.2.4. New Product Development

Chapter 13. Key Vendor Analysis
13.1. Genome Medical, Inc
13.1.1. Business Overview
13.1.2. Product Benchmarking
13.1.3. Financial Data
13.1.4. Strategic Overview
13.1.5. Key Developments
13.1.6. SWOT Analysis
13.2. BioMed Central Ltd
13.2.1. Business Overview
13.2.2. Product Benchmarking
13.2.3. Financial Data
13.2.4. Strategic Overview
13.2.5. Key Developments
13.2.6. SWOT Analysis
13.3. Aevi Genomic Medicine, Inc.
13.3.1. Business Overview
13.3.2. Product Benchmarking
13.3.3. Financial Data
13.3.4. Strategic Overview
13.3.5. Key Developments
13.3.6. SWOT Analysis
13.4. Congenica Ltd.
13.4.1. Business Overview
13.4.2. Product Benchmarking
13.4.3. Financial Data
13.4.4. Strategic Overview
13.4.5. Key Developments
13.4.6. SWOT Analysis
13.5. Deep Genomics
13.5.1. Business Overview
13.5.2. Product Benchmarking
13.5.3. Financial Data
13.5.4. Strategic Overview
13.5.5. Key Developments
13.5.6. SWOT Analysis
13.6. Editas Medicine
13.6.1. Business Overview
13.6.2. Product Benchmarking
13.6.3. Financial Data
13.6.4. Strategic Overview
13.6.5. Key Developments
13.6.6. SWOT Analysis
13.7. Illumina, Inc.
13.7.1. Business Overview
13.7.2. Product Benchmarking
13.7.3. Financial Data
13.7.4. Strategic Overview
13.7.5. Key Developments
13.7.6. SWOT Analysis
13.8. QIAGEN N.V. (Thermo Fisher Scientific)
13.8.1. Business Overview
13.8.2. Product Benchmarking
13.8.3. Financial Data
13.8.4. Strategic Overview
13.8.5. Key Developments
13.8.6. SWOT Analysis
13.9. Agilent Technologies, Inc.
13.9.1. Business Overview
13.9.2. Product Benchmarking
13.9.3. Financial Data
13.9.4. Strategic Overview
13.9.5. Key Developments
13.9.6. SWOT Analysis
13.10. Bio-Rad Laboratories, Inc.
13.10.1. Business Overview
13.10.2. Product Benchmarking
13.10.3. Financial Data
13.10.4. Strategic Overview
13.10.5. Key Developments
13.10.6. SWOT Analysis
13.11. F. Hoffmann-La Roche Ltd.
13.11.1. Business Overview
13.11.2. Product Benchmarking
13.11.3. Financial Data
13.11.4. Strategic Overview
13.11.5. Key Developments
13.11.6. SWOT Analysis
13.12. BGI
13.12.1. Business Overview
13.12.2. Product Benchmarking
13.12.3. Financial Data
13.12.4. Strategic Overview
13.12.5. Key Developments
13.12.6. SWOT Analysis

Chapter 14. Future Outlook of the Market